Interferon-beta and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
Niall Stewart, Steve Simpson, Ingrid van der Mei, Anne-Louise Ponsonby, Leigh Blizzard, Terrence Dwyer, Fotini Pittas, Darryl Eyles, Pauline Ko, Bruce V Taylor
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2012
Awarded by Australian National Health & Medical Research Council
The MS Longitudinal Study was funded by a grant from the Australian National Health & Medical Research Council (Project 211308). Additional funding for 25(OH)D measures provided by the Trish Foundation. Additional funding for 1,25(OH)<INF>2</INF>D measures provided by a University of Tasmania Rising Star Award. I.v.d.M. is supported by a Future Fellowship from the Australian Research Council.